Stephens Consulting, LLC - KEMPHARM INC ownership

KEMPHARM INC's ticker is KMPH and the CUSIP is 488445206. A total of 70 filers reported holding KEMPHARM INC in Q4 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.

Quarter-by-quarter ownership
Stephens Consulting, LLC ownership history of KEMPHARM INC
ValueSharesWeighting
Q3 2023$9,640
-5.5%
2,0000.0%0.00%0.0%
Q2 2023$10,200
-7.3%
2,0000.0%0.00%
-42.9%
Q1 2023$11,000
+19.8%
2,0000.0%0.01%
+16.7%
Q4 2022$9,180
-26.4%
2,0000.0%0.01%
-45.5%
Q3 2022$12,480
+39.9%
2,0000.0%0.01%
+57.1%
Q2 2022$8,920
-11.3%
2,0000.0%0.01%
-12.5%
Q1 2022$10,060
-48.1%
2,000
-10.1%
0.01%
-50.0%
Q4 2021$19,3802,2250.02%
Other shareholders
KEMPHARM INC shareholders Q4 2022
NameSharesValueWeighting ↓
Ground Swell Capital, LLC 14,219$131,0000.42%
Arete Wealth Advisors, LLC 52,844$486,0000.06%
SG3 Management, LLC 187,100$1,721,0000.04%
Pensionmark Financial Group, LLC 13,850$118,0000.03%
Virtu Financial LLC 38,196$351,0000.02%
CNB Bank 3,000$28,0000.02%
HAP Trading, LLC 110,200$295,0000.02%
Engineers Gate Manager LP 31,700$292,0000.01%
Harel Insurance Investments & Financial Services Ltd. 20,000$615,0000.01%
Tower Research Capital LLC (TRC) 64,985$597,0000.01%
View complete list of KEMPHARM INC shareholders